1 enrolling by invitation, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Fuling Zhou: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma a combination treatment of Linperlisib and the VRD regimen - Newly Diagnosed Multiple Myeloma | Phase 1 / Phase 2 | Not yet recruiting | Fuling Zhou | 42 | 2025-02-01 | 2025-01-29 |
| Helical Tomotherapy in Multiple Myeloma Total Marrow irradiation，TMI, Autologous hematopoietic stem cell transplantation - Multiple Myeloma | Not applicable | Recruiting | Fuling Zhou | 58 | 2023-06-14 | 2023-08-01 |
| Double Filtration Plasmapheresis Combined With Chemotherapy DFPP combined with chemotherapy - Multiple Myeloma | Phase 1 | Unknown | Fuling Zhou | 20 | 2021-05-15 | 2023-07-13 |
| AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities Multiple Myeloma | Enrolling by invitation | Fuling Zhou | 10 | 2018-08-01 | 2026-02-13 |
Multiple Myeloma (4) · Neoplasms, Plasma Cell (1)
Drug Therapy (1)
China (4)